Matching articles for "Ustekinumab (Stelara) for Psoriasis"

Addendum: Cost of Ustekinumab (Stelara)

   
The Medical Letter on Drugs and Therapeutics • March 8, 2010;  (Issue 1333)
In the Medical Letter article on ustekinumab (Stelara) for psoriasis (2010; 52:7), footnote 2 in table 2 should have included a second sentence: $5595.60 is the cost of one 45-mg...
In the Medical Letter article on ustekinumab (Stelara) for psoriasis (2010; 52:7), footnote 2 in table 2 should have included a second sentence: $5595.60 is the cost of one 45-mg syringe.
Med Lett Drugs Ther. 2010 Mar 8;52(1333):20 | Show Full IntroductionHide Full Introduction

Ustekinumab (Stelara) for Psoriasis

   
The Medical Letter on Drugs and Therapeutics • January 25, 2010;  (Issue 1330)
The FDA has approved the use of ustekinumab (Stelara - Centocor Ortho Biotech), an interleukin antagonist given by subcutaneous (SC) injection for treatment of adults with moderate to severe plaque psoriasis....
The FDA has approved the use of ustekinumab (Stelara - Centocor Ortho Biotech), an interleukin antagonist given by subcutaneous (SC) injection for treatment of adults with moderate to severe plaque psoriasis. It is the first agent in its class for this indication; the other biologic agents for psoriasis are Tcell or tumor necrosis factor (TNF) inhibitors.
Med Lett Drugs Ther. 2010 Jan 25;52(1330):7-8 | Show Full IntroductionHide Full Introduction